Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion description "[Mice immunized with murine mammary carcinoma cells genetically engineered to secrete interleukin-2 (IL-2) are rendered resistant to subsequent challenge with unmodified tumor cells, and in the case of mice bearing established tumors, the rate of development of pulmonary metastases is reduced.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion evidence source_evidence_literature NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion SIO_000772 9259972 NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion wasDerivedFrom befree-20150227 NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion wasGeneratedBy ECO_0000203 NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- befree-20150227 importedOn "2015-02-27" NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.